(NASDAQ: AVXL) Anavex Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.59%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.49%.
Anavex Life Sciences's earnings in 2025 is -$47,141,000.On average, 1 Wall Street analyst forecast AVXL's earnings for 2025 to be -$44,393,363, with the lowest AVXL earnings forecast at -$44,393,363, and the highest AVXL earnings forecast at -$44,393,363.
In 2026, AVXL is forecast to generate -$41,832,207 in earnings, with the lowest earnings forecast at -$41,832,207 and the highest earnings forecast at -$41,832,207.